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Background: Diabetic Neuropathy is a condition that damages nerve in the body. High blood sugar levels affect
the way nerves use glucose leading to an accumulation of sugar SORBITOL as depletion of substance called
MYOINOSITOL with in nerves, contributing to nerve damage. Historically De calvi first showed the relationship
between diabetes and peripheral nerve damage.  Diabetes Mellitus is predicted to afflict 220 Million people
worldwide by the year 2010, and approximately 30-60% of patients with Diabetes develop long-term of peripheral
neuropathy and upto 10 to 20% of these patients experience pain.  Pirart8, showed the incidence of Diabetic
Neuropathy to be 7.5% at the time of diagnosis with a 1.7% annual increase. [International Diabetes Federation].
Method:  Thirty subjects were divided equally 2 groups each containing  subjects Group A were given TENS,
(mean age 53.2, while group B was given  placebo TENS mean age of 50.8 and Visual Analog Scale [VAS] scores
> 5 were calculated and data collected for all the subjects prior to the treatment and after the treatment
intervention. Wilcoxon method was used for analysis.
Results: The Experimental group (N=15) used TENS, the mean of Pre-treatment VAS Score is 8.46 and Post-
treatment VAS Score is 2.6..And statistically when observed by using the Wilcoxon signed ranks test the obtained
T Value =7 and it shows a significant.
Discussion: There are 2 potential mechanisms by which High – Frequency TENS can relieve the pain of diabetic
neuropathy.  It is possible that TENS alleviates pain by directly blocking abnormal spontaneous activity in small
diameter pain mediating peripheral nerves.  This mechanism requires electrical stimulation to be applied directly
to spontaneously active nerve.  In addition TENS can relieve the pain of diabetic neuropathy by altering
nociceptive transmission in the dorsal horn of spinal cord.  The second mechanism requires that stimulation be
delivered to spinal cord segments that innervate the painful area.
Conclusion: TENS has shown a significant improvement on neuropathic pain in diabetic neuropathy patients
when compare to the Placebo TENS and hence alternate Hypothesis is accepted Null Hypothesis is rejected.
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Diabetic Neuropathy is a condition that damages
nerve in the body.  High blood sugar levels
affects the nerves that uses glucose leading to
an accumulation of sugar SORBITOL as depletion
of substance called MYOINOSITOL with in
nerves, contributing to nerve damage. Histori-
cally De calvi first showed the relationship
between diabetes and peripheral nerve damage.
Diabetes Mellitus is predicted to affect 220  Mill-
ion people worldwide by the year 2010, and
approximately 30-60% of patients with Diabe-
tes develop long-term of peripheral neuropathy
and up to 10 to 20% of these patients experi-
ence pain.  Pirart8, showed the incidence of
Diabetic Neuropathy to be 7.5% at the time of
diagnosis with a 1.7% annual increase. [Interna-
tional Diabetes Federation].  Pain arises from
excessive stimulation of sensory end organ.  Pain
from summation above a critical at dorsal horn.Int J Physiother Res 2014;2(4):604-07.     ISSN 2321-1822 605
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neurons. Lesions of central nervous system can
abolish pain exclusively. Pain elicited A and C
fibers Pathological associated with inflamma-
tion, Neuropathy. Transcutaneous electrical
nerve stimulation [TENS] currently is one of the
most commonly used forms of electro analge-
sia.  Hundreds of clinical reports exist concern-
ing the use of TENS for various types of condi-
tions such as low back pain (LBP). Myofascial and
arthritic pain, sympathetically mediated pain,
bladder  incontinence, visceral pain, and post
surgical pain.
The Aim of the study is to find out the variation
in pain intensity using Transcutaneous  Electrical
Nerve  Stimulation  [TENS]  in  Diabetic
Neuropathic Pain Patients.  Objective of this
study is to understand the physiological changes
that  occur  in  Diabetic  Neuropathic  Pain
individuals,  with  the  application  of
Transcutaneous Electrical Nerve Stimulation
[TENS].
Null Hypothesis: There will be no effect of TENS
on Neuropathic pain in Diabetic Neuropathic
Patients.
Alternative  Hypothesis:  There  will  be  a
significant decrease in Neuropathic pain in
Diabetic  Neuropathy  patients  with  the
application of TENS.
METHODOLOGY
Thirty subjects were divided equally 2 groups
each containing  subjects Group A were given
TENS, (mean age 53.2, while group B was given
place bo TENS mean age of 50.8 and  Visual
Analog Scale [VAS] scores > 5 were calculated
and data collected for all the subjects prior to
the  treatment  and  after  the  treatment
intervention.
Wilcoxon method was used for analysis.
Source of data
Subjects diagnosed with diabetic neuropathy.
Suffering with neuropathic pain referred for
physiotherapy from
1. Department of Physiotherapy, School of
Physiotherapy RK University.
2. Department of Physiotherapy, Extension of
School of Physiotherapy Bhakthinagar Circle, RK
university.
Method of Collection of Data: Type of sampling:
Randomized Controlled Sampling Sample Size is
30 Individuals.
Table 1: Showing the Sample and interventions used.
Intervention Subjects Age Group
Group A TENS 15 40 – 70 Years
Group B Placebo TENS 15 40 – 70 Years
Graph 1: showing the comparision between
Pre-treatment and Post treatment TENS Group A
(0-4 Weeks).
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Graph 2: showing the comparision between Pre-
treatment and Post treatment Placebo TENS Group B
(0-4 Weeks).
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The group A (Experimental Group ) received the
treatment frequency of 100 HZ  and Pulse width
is 200-400 micro seconds and intensity is
tolerable limit and the session are 2 session per
day for 4 weeks and 6 days per week and the
total duration of the treatment was 24 days
The Group B (Placebo Group ) the frequency is
0HZ and Pulse width is 0 microseconds and
intensity is 0 seconds and duration is 20 minutes
and 2 session per day and the total duration  isInt J Physiother Res 2014;2(4):604-07.     ISSN 2321-1822 606
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Control group (Placebo TENS):
The above positioning of electrodes, pain assess-
ment chart, duration and time period is same as
the experimental group.  Here the frequency is
maintained – 0, Pulse width is 0 and intensity is
– 0, duration is 20 minutes 2 sessions/day.
24 days 4 weeks 6 days per week.
Type of Study: Experimental Study
Materials used: Treatment Table, Pillow, Cotton,
Conductive Gel, TENS unit, Visual Analog Scale
(Assessment Chart).
For this Study we included the subjects between
the Age group of 40-70 years of the both
genders, with [Type I & II] diabetes mellitus and
they diagnosed as Diabetic Neuropathy and
having  Neuropathic  Pain  [Feet,  lower
extremities, low – back], and Visual Analog Scale
[VAS] more then 5. Exclusive Criteria included
Total loss of sensation, Spinal injuries, Perceptual
disorders,  Patients  with  musculo  skeltel
disorders, Patients with associated Neurologic
disorders.
PROCEDURE
Experimental Procedure
The physical therapist prepared the skin by
gently cleaning it with an alcohol wipe.  A self
adhesive surface electrode was placed about
1.3cm (1/2 inch) lateral to the right posterior
superior iliac spine on the back.  A second
electrode was placed in the same position on
the left side of the back.
The electrodes were attached to a Dual Channel
table top TENS (INDOTENS) Transcuatenous
Electric Nerve Stimulation set at a constant
frequency of 100Hz, the pulse width can be
adjustable 200-400 micro seconds and duration
is 20 minutes.  The intensity of stimulation was
slowly increased until the patient could perceive
the  stimulation  but  was  not  made
uncomfortable. The methods were used to
assess the patient’s perception of pain.  The first
was used once on initial evaluation.  The patient
was asked to express the magnitude of pain on
a scale of 0 to 10, with 0 being “no pain atoll and
10 being the worst pain you can imagine the
second assessment was used to document the
area of body that was painful.  The patient was
given a sketch of the body and was asked to draw
the areas of his or her body that were painful.
The patients drawing were consistent with his
or her description of the location and extent of
painful area. Finally the patient was given a
Visual Analog Scale (VAS) was used to assess the
intensity of perceived pain. A Visual Analog Scale
(VAS) was used to assess the intensity of
perceived pain.  For each painful area identified,
the patient was given a 10 cm line and asked to
draw on the line the intensity of pain he or she
was feeling the left end of the line represented
“no pain at all” and the right end of the line
represented the “worst pain you can imagine”.
The patient’s mark on the line was measured (in
cm) with a ruler. The VAS is a reliable and valid
tool for the quantification of perceived pain. The
session of TENS treatment is 2 time / day with a
duration of 20 minutes and whole treatment
time is 3 weeks.
RESULTS
The Experimental group (N=15) used TENS, the
mean of Pre-treatment VAS Score is 8.46 and
Post-treatment VAS Score is 2.6.
The Statistical data is analyzed by using Wilcoxon
signed-ranks test i.e. P value  < 0.05, and the T
value 7, which represent the Significance of
TENS, and checked with Wilcoxon Probability
table i.e. one failed for  N=14 the obtained values
are.
.05 .25 .01 .005
 2.6 21 16 13
  7 7  7   7
When Compare with Wicoxon Probability Values
(T=7, N=4) the TENS is significant on neuropathic
pain in diabetic neuropathy patients.
In Controlled group (Placebo TENS) (N=5), the
mean of Pre treatment VAS Score is 7.466, and
Post – treatment VAS score is 8.26, The T=78
(N=12) which can be observed in Wilcoxon
Probability table.
0.05 0.25 0.01 0.005
N=12 17 14 10 7
T=78 78 78 78 78
T value were compared Pd”0.05 is not Significant
When Compared the TENS (T=7, N=14) with
Placebo TENS (T=78, N=12), TENS is significant
effect in decreasing the intensity of pain.Int J Physiother Res 2014;2(4):604-07.     ISSN 2321-1822 607
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DISCUSSION
There are 2 potential mechanisms  by which High
– Frequency TENS can relieve the pain of diabetic
neuropathy.  It is possible that TENS alleviates
pain by directly blocking abnormal spontaneous
activity in small diameter pain mediating
peripheral nerves.  This mechanism requires
electrical stimulation to be applied directly to
spontaneously active nerve.  In addition TENS
can relieve the pain of diabetic neuropathy by
altering nociceptive transmission in the dorsal
horn of spinal cord.  The second mechanism
requires that stimulation be delivered to spinal
cord segments that innervate the painful area.
David L Somers and Martha F Somers  in his case
report, suggest the use of TENS may be an
effective treatment for the pain of diabetic
neuropathy. In experimental [TENS] Group-A [N
= 14] the 8th and 13th subject it is observed that
the intensity of pain is increased moderately to
severe.  The reason is that, these patients are
not under stable glycemic control.
In controlled [Placebo TENS] Group-B (N=12) the
subject is decreased the intensity of pain in 1
cm i.e. due to the stable glycemic control.
CONCLUSION
Patients with Diabetic neuropathic pain have
shown significant improvement in the decreased
intensity of the pain after treating with TENS and
Placebo TENS In both the groups.  But this
improvement was seen more in patients (Group-
A) receiving TENS.  Improvement in decreased
pain as seen on VAS score used for assessing.
TENS has shown a significant improvement on
neuropathic pain in diabetic neuropathy patients
when compare to the Placebo TENS and hence
alternate Hypothesis is accepted Null Hypothesis
is rejected.
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